The Hemostatic Agents Market to gain from increasing number of surgical procedures conducted worldwide. A new report is published by Fortune Business Insights that anticipated to expand at a CAGR of 6.4% and reach US$ 5441.5 Mn by the end of 2025.
Pune, India – May 16, 2019 —
The Global Hemostatic Agents Market to gain from increasing number of surgical procedures conducted worldwide. A new report is published by Fortune Business Insights, titled “Hemostatic Agents Market Size, Share and Global Trend By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery & Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers) and Geography Forecast till 2025.” As per the report, in 2017 the global hemostatic agents market was worth US$ 3339.4 Mn. The global market is anticipated to expand at a CAGR of 6.4% and reach US$ 5441.5 Mn by the end of 2025.
The hemostatic agents market in Asia Pacific is expected to grow at a relatively higher CAGR. Baxter (the leading organization in global market), plans to expand its operation in emerging nations such as India and China to enhance its accessibility. This is expected to propel the growth rate of the Asia Pacific hemostatic agents market. Meanwhile, the Europe market is likely to expand at a low CAGR due to the presence of a smaller patient pool compared to Asia Pacific and North America.
Request sample copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemostatic-agents-market-100084
The report classifies the global hemostatic agents market in terms of various segments and offers a comprehensive overview. According to the report the hemostatic agents market in North America was valued at US$ 1173 Mn in 2017. The North America market was leading at a global sphere in the same year. According to the report, the trend is unlikely to change during the forecast period 2018-2025. Growth the market witnessed in North America is attributable to the increasing demand for surgical procedure in the region. Besides this, as per a research conducted by the American College of Obstetricians and Gynecologist, in the U.S. the rate of postpartum hemorrhage increased by 25.9% approximately during the last decade. This is likely to fuel the demand for hemostatic agents for surgery and other purposes
Combination Hemostats to Dominate the Global Market
In terms of product type, the combination hemostats segment accounted for 14% of the global market in 2017. Combination hemostats are proven to be very effective and offer faster healing. Combination hemostats are capable of offering efficient hemostasis in shorter time owing to rapid action of thrombin and gelatin. Rising adoption of combination hemostats is anticipated to drive the global hemostatic agents market during the forecast period 2018-2025.
The factors expected to drive the global hemostatic agents market are increasing incidence of hemorrhage during surgery and rising emphasis on blood management. Moreover, innovations in surgical procedure such as robot assisted surgery and rising geriatric population are anticipated to fuel the demand in global hemostatic agents market.
As per data published by the Journal of medical Emergency Services (JEMS), worldwide approximately 5 million people die due to traumatic and non-traumatic hemorrhage. Therefore, the rising cases of traumatic or non-traumatic hemorrhage is likely to enable growth in the global hemostatic agents market.
Baxter Widening its Distribution Network Across Regions
Baxter emerged dominant in the global hemostatic agents market in 2017. The growth witnessed is attributable to its diversification strategy implemented to improve the accessibility of its brands. The trend is unlikely to change and Baxter may continue to dominate the global market during forecast period. Strong brand presence, diversified product portfolio, and intense R&D conducted on hemostatic agents are a few factor contributing to Baster’s expansion. Some of the other companies operating in the global hemostatic agents market are Stryker, CryoLife Inc., Integra Life Sciences, BD, Ethicon LLC., Pfizer Inc., Medtronic, and Biom’up.
Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemostatic-agents-market-100084
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune – 411045, Maharashtra, India.
Phone: 1 424 253 0390
This content is not produced by Reuters Editorial News. It is produced by VC NewsNetwork. For content enquiry, please reach us at
Givaudan, the Swiss flavors and fragrances company will be acquiring Golden Frog to strengthen its presence in the Asia Pacific region.
Indonesian ecommerce unicorn Bukalapak has launched BukaGlobal, a new feature that lets consumers outside Indonesia shop on the Bukalapak platform.
This marks Centara’s entry into one of the world’s fastest-growing tourism markets and enables the company to secure a major Myanmar foothold.
This marks the biggest funding round for a fintech company in the SEA region.
The Ubisoft accelerator is bringing its startup incubator programme to Singapore for the first time.